Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Kuvan effects on meal-induced oxidative stress in PKU
NCT01395394Phase 2Terminated
- Sponsor
- Emory University
- Start
- Jun 2011
- Primary completion
- Jun 2013
- Modality
- Allosteric Modulators, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 2 trial of sapropterin in phenylketonuria (PKU), sponsored by Emory University. Started Jun 2011; status: terminated.
02
Drugs
sapropterin
03
Conditions
phenylketonuria (PKU)
Beyond the preview
Go deeper on NCT01395394.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01395394.